Lifecome Biochemistry Co.,Ltd. (SHE:002868)
22.52
+0.36 (1.62%)
Aug 4, 2026, 3:04 PM CST
Lifecome Biochemistry Revenue
Lifecome Biochemistry had revenue of 119.43M CNY in the quarter ending June 30, 2026, a decrease of -21.40%. This brings the company's revenue in the last twelve months to 470.43M, down -23.73% year-over-year. In the year 2025, Lifecome Biochemistry had annual revenue of 516.58M, down -20.45%.
Revenue (ttm)
470.43M
Revenue Growth
-23.73%
P/S Ratio
7.44
Revenue / Employee
856.88K
Employees
549
Market Cap
3.50B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 516.58M | -132.79M | -20.45% |
| Dec 31, 2024 | 649.37M | 142.37M | 28.08% |
| Dec 31, 2023 | 507.00M | 177.15M | 53.71% |
| Jan 1, 2023 | 329.85M | -33.54M | -9.23% |
| Dec 31, 2021 | 363.39M | 55.24M | 17.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hefei Lifeon Pharmaceutical | 1.55B |
| Kexing Biopharm | 1.46B |
| Pulike Biological Engineering | 1.06B |
| Boji Medical Technology | 949.94M |
| Assure Tech (Hangzhou) | 407.16M |
| Jiangsu Sihuan Bioengineering | 381.71M |
| Beijing Scitop Bio-tech | 373.31M |
| Jiangsu Bioperfectus Technologies | 326.02M |